Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Verastem ( (VSTM) ) is now available.
On November 13, 2025, Verastem, Inc. entered into an underwriting agreement with Jefferies LLC and Guggenheim Securities, LLC for a public offering of its common stock and pre-funded warrants, expecting to raise approximately $96.9 million. The offering, which includes an option for underwriters to purchase additional shares, is set to close on November 17, 2025, and is part of Verastem’s strategy to strengthen its financial position.
The most recent analyst rating on (VSTM) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Verastem stock, see the VSTM Stock Forecast page.
Spark’s Take on VSTM Stock
According to Spark, TipRanks’ AI Analyst, VSTM is a Neutral.
Verastem’s overall stock score is primarily impacted by its weak financial performance, characterized by ongoing losses and negative equity. However, positive technical indicators and recent corporate events, such as the $75M private placement, provide some optimism for future growth. Valuation remains constrained by negative earnings, but strategic initiatives and product development efforts could drive improvements. The stock represents a speculative opportunity, with potential upside if financial health and operational efficiencies improve.
To see Spark’s full report on VSTM stock, click here.
More about Verastem
Average Trading Volume: 2,349,214
Technical Sentiment Signal: Hold
Current Market Cap: $504.5M
See more data about VSTM stock on TipRanks’ Stock Analysis page.